Form D · Hedge Fund

GT Biotech Fund, LP

Memphis, TN · CIK 0001806841

Offering snapshot reported Jul 29, 2026 · SEC filing

Reported sold
$234M
Indefinite offering
Investors reported
314
Form D · investor count
Minimum accepted
$5K
Reported outside-investor minimum
First sale
Apr 1, 2020
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$117M$234MJul 30, 2021: $104,447,958.00Jul 30, 2021Jul 29, 2022: $194,584,265.00Jul 29, 2022Jul 28, 2023: $217,038,865.00Jul 28, 2023Jul 29, 2024: $221,588,865.00Jul 29, 2024Jul 29, 2025: $229,257,953.00Jul 29, 2025Jul 29, 2026: $233,540,857.00Jul 29, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$229,257,953 → $233,540,857
  • Reported investors304 → 314
  • Minimum accepted$16,000 → $5,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 29, 2026Amendment$233,540,857$4,282,904vs Jul 29, 2025314SEC filing
Jul 29, 2025Amendment$229,257,953$7,669,088vs Jul 29, 2024304SEC filing
Jul 29, 2024Amendment$221,588,865$4,550,000vs Jul 28, 2023313SEC filing
Jul 28, 2023Amendment$217,038,865$22,454,600vs Jul 29, 2022297SEC filing
Jul 29, 2022Amendment$194,584,265$90,136,307vs Jul 30, 2021276SEC filing
Jul 30, 2021Amendment$104,447,958No comparisonNot reportedSEC filing
Mar 16, 2021Amendment$61,216,436$45,251,436vs Apr 13, 2020132SEC filing
Apr 13, 2020Amendment$15,965,000No comparison50SEC filing
Mar 16, 2020InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.1, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-362969

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
AMD Capital, LLC121539
Harbor Financial Services, LLC25700
Lion Street Financial, LLC165828

Source: Form D, filed Jul 29, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

GT BIOTECH FUND, LP

Investment adviser: GERBER/TAYLOR MANAGEMENT LLC

Gross asset value
$358M
Beneficial owners
276
ADV minimum commitment
$250K

Reported in Form ADV on Jul 1, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator UMB FUND SERVICES OGDEN, Utah, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor ELLIOTT DAVIS CHATTANOOGA, Tennessee, United States
Custodian TRUIST BANK MEMPHIS, Tennessee, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

ELLIOTT DAVIS
PCAOB 149

TRUIST BANK
LEI JJKC32MCHWDI71265Z06

Filing source

Form ADV 2091400 · Jul 1, 2026 · Schedule D 7.B.(1), fund 805-3947357215

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mary C. Cornpropst Executive
Michael J. Douglass Executive
David G. East Executive
Charles C. Gerber Executive
N/A Gerber/Taylor Management Company Promoter
N/A Gerber/Taylor Management Llc Executive
Ryan E. Gibbs Executive
Darren Kearns Executive
Simone T. Meeks Executive
William E. Pickens Executive
Justin L. Rikard Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
40 S. Main Street Suite 1900
Memphis, TN, 38103